Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Mar 14.
Published in final edited form as: N Engl J Med. 2017 Sep 14;377(11):1099–1101. doi: 10.1056/NEJMc1708223

Vaccination Rates among Younger Siblings of Children with Autism

Gena Glickman 1, Elizabeth Harrison 1, Karen Dobkins 1
PMCID: PMC5745801  NIHMSID: NIHMS921568  PMID: 28902586

To the Editor

Recent outbreaks of illnesses that may be prevented by vaccines have increased public debate about vaccination behaviors (i.e., whether or not and when parents choose to vaccinate a child), and California has been a key affected state. One reason that parents choose not to have their children vaccinated is the perceived link between vaccines and autism spectrum disorder. This reason is particularly relevant for parents of a child who has autism spectrum disorder, since concerns that the disorder will develop in subsequent children may be more pronounced.

Since 2009, we have tracked the development of infants who have a full biologic older sibling with a diagnosis of autism spectrum disorder. The risk of this disorder is increased by a factor of approximately 20 among these “high-risk” infants.1 Our comparisons of such infants with age-matched “low-risk” infants who have an older sibling without autism spectrum disorder allows for the identification of putative biomarkers of this disorder.2 Although vaccination behaviors were not our primary focus, studies showing decreased rates of vaccination against measles–mumps–rubella (MMR) among high-risk infants prompted us to analyze available data on vaccination behaviors in our sample of 206 families from southern California (71 of which had a child with autism spectrum disorder and 135 that did not have a child with autism spectrum disorder) (Table 1).3,4

Table 1.

Demographic Characteristics of Older Siblings, Infants, and Mothers, According to Group.*

Characteristic Older Siblings Infants
Autism Spectrum Disorder (N = 71) Typically Developing (N = 135) With Older Sibling Who Has Autism Spectrum Disorder (High-Risk) (N = 71) With Typically Developing Older Sibling (Low-Risk) (N = 135)
Age (mo) 56.6±3.0 52.4±3.1 5.4±0.5 6.7±0.5

Female sex (%) 11.3 51.1 46.5 43.0

Race or ethnic group (%)

 White 64.8 65.7

 Hispanic 28.4 18.8

 Black 2.6 0

 Asian 7.0 7.5

 Mixed race or other race 19.7 20.1

Maternal age (yr) 34.5±0.5 35.4±0.4

Maternal education (%)

 Less than high school 1.4 0

 High school diploma or equivalent 18.3 10.4

 Some postsecondary education 18.3 14.2

 Bachelor’s degree 35.2 37.3

 Master’s degree 18.3 30.6

 Professional degree: Ph.D. or M.D. 8.4 7.5
*

Plus–minus values are means ±SE. Older siblings are the closest sibling in age to the infant, with the exception of seven older siblings in the autism spectrum disorder group. Student’s t-tests were performed to compare ages across groups, with Welch’s correction to adjust for unequal variances in comparisons of older siblings and infants. Categorical data are shown as a percentage for each group, and chi-square analyses were used to investigate differences between the groups. The following data were missing and were therefore excluded from analyses: race (1 child–infant pair in the low-risk group), ethnic group (2 in the low-risk group and 3 in the high-risk group), education (1 in the low-risk group), and maternal age (1 in the high-risk group). In addition, the presence of “0” values in some cells resulted in exclusion of the variables “black” and “less than high school” from group comparisons. Since the sample included only full biologic siblings, categorical data for the older sibling and infant counterpart are identical, except for sex. Older siblings with autism spectrum disorder were more likely to be male than typically developing older siblings (P<0.001). P ≥ 0.10 for all other comparisons.

Race or ethnic group was reported by the parents, who could report more than one race or ethnic group.

Childhood vaccination and autism spectrum disorder continue to be linked in the minds of many people despite overwhelming evidence to the contrary.5 Adding to this evidence, our data showed no significant difference between rates of vaccination among children with and those without autism (100.0% vs. 98.5%; P = 0.30). However, there were two additional interesting findings. Families with children who had autism spectrum disorder were less likely to vaccinate subsequent children. Specifically, the rate of vaccination among full biologic infant siblings of children with autism spectrum disorder was 83.1%, as compared with 97.0% among low-risk infants (Pearson chi-square value with one degree of freedom, 12.62; P<0.001). These findings are consistent with reported rates of MMR vaccination among children at older ages and across broader sampling regions.3,4

Our results also suggest that changes in vaccination behavior may relate to adverse reactions to vaccine. In particular, parents who had an older child with autism spectrum disorder retrospectively reported a higher rate of adverse reactions to vaccination among the older child than did those who did not have an older child with autism (22.6% vs. 3.8%; Pearson chi-square value with one degree of freedom, 16.87; P<0.001). Likewise, parents who had an older child with autism retrospectively reported a higher rate of these reactions among the infant sibling than autism (6.9% vs. 0.8%; Pearson chi-square value with one degree of freedom, 5.87; P = 0.02). Reported reactions included fever, diarrhea, unusual crying or screaming, and general malaise. These differences in reported reactions may reflect either a true increase or a recall bias, and they warrant larger prospective studies of adverse reactions to vaccine with the use of more objective measures, such as medical records and examination after vaccination, in children in whom autism spectrum disorder ultimately develops.

The relationship between adverse reactions to vaccine and autism spectrum disorder has received little attention in research as of this writing. At the public health level, a better understanding of the relationship between perceived adverse reactions to vaccine and autism spectrum disorder is necessary in order to more effectively address concerns about vaccination.

THIS WEEK’S LETTERS.

1099 Vaccination Rates among Younger Siblings of Children with Autism
1101 Head Positioning in Acute Stroke
1103 Transplanting HCV-Infected Kidneys into Uninfected Recipients

Acknowledgments

Supported by grants from the Congressionally Directed Medical Research Program, Autism Research Program (AR130253, to Drs. Glickman and Dobkins), and the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (R01 HD052804-01A2, to Dr. Dobkins).

Footnotes

Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.

References

  • 1.Ozonoff S, Young GS, Carter A, et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011;128(3):e488–95. doi: 10.1542/peds.2010-2825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Penn AH, Carver LJ, Herbert CA, et al. Breast milk protects against gastrointestinal symptoms in infants at high risk for autism during early development. J Pediatr Gastroenterol Nutr. 2016;62:317–27. doi: 10.1097/MPG.0000000000000907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Jain A, Marshall J, Buikema A, Bancroft T, Kelly JP, New-schaffer CJ. Autism occurrence by MMR vaccine status among US children with older siblings with and without autism. JAMA. 2015;313:1534–40. doi: 10.1001/jama.2015.3077. [DOI] [PubMed] [Google Scholar]
  • 4.Kuwaik G, Roberts W, Brian J, et al. Immunization uptake in siblings of children with autism. Pediatrics. 2008;122:684–5. doi: 10.1542/peds.2008-1624. [DOI] [PubMed] [Google Scholar]
  • 5.Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32:3623–9. doi: 10.1016/j.vaccine.2014.04.085. [DOI] [PubMed] [Google Scholar]

RESOURCES